The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis

• Prif Awduron: Ann Logan (Awdur), Antonio Belli (Awdur), Valentina Di Pietro (Awdur), Barbara Tavazzi (Awdur), Giacomo Lazzarino (Awdur), Renata Mangione (Awdur), Giuseppe Lazzarino (Awdur), Inés Morano (Awdur), Omar Qureshi (Awdur), Lars Bruce (Awdur), Nicholas M. Barnes (Awdur), Zsuzsanna Nagy (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background: Acute and chronic neurodegenerative diseases represent an immense socioeconomic burden that drives the need for new disease modifying drugs. Common pathogenic mechanisms in these diseases are evident, suggesting that a platform neuroprotective therapy may offer effective treatments. Here...